XML 20 R2.htm IDEA: XBRL DOCUMENT v3.24.4
CONSOLIDATED BALANCE SHEETS - USD ($)
Nov. 30, 2024
Aug. 31, 2024
Current    
Cash $ 8,078,254 $ 6,499,885
Marketable securities 39,875 55,807
Accounts receivable 263,491 154,477
Prepaid expenses and other current assets 444,121 1,187,817
Total Current Assets 8,825,741 7,897,986
Non-current assets, net    
Long-term receivables 64,014 63,575
Right of use assets 128,025 134,843
Intellectual property, net 505,373 516,676
Property & equipment, net 270,621 254,709
Total Non-current Assets 968,033 969,803
TOTAL ASSETS 9,793,774 8,867,789
Current Liabilities    
Accounts payable and accrued liabilities 268,986 1,066,409
Deferred revenue 0 4,963
Lease liability, current 28,812 28,047
Total Current Liabilities 297,798 1,099,419
Lease liabilities non - current 101,920 109,319
TOTAL LIABILITIES 399,718 1,208,738
Stockholders' Equity    
Share Capital Authorized: 220,000,000 common voting shares with a par value of $0.001 per share Common shares issued and outstanding: 17,452,594 and 15,810,205 at November 30, 2024, and August 31, 2024, respectively 17,453 15,810
Additional paid-in capital 64,042,343 59,599,178
Accumulated Deficit (54,262,471) (51,558,772)
Accumulated other comprehensive loss (22,991) (19,816)
Equity attributable to shareholders of Lexaria 9,774,334 8,036,400
Non-controlling Interest (380,278) (377,349)
Total Stockholders' Equity 9,394,056 7,659,051
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 9,793,774 $ 8,867,789